Research Summaries Book

Melanie Caudron

Description

20 Jun 2002 – Supported by AFAR Postdoctoral Grant, and NIH Grants DK-41814, ..... Gynecology (J.E.N.), Med Coll of Virginia, Virginia Commonwealth Univ, Richmond, VA. ...... HIV-1 Accessory Protein Vpr Interacts with 14-3-3 Proteins Causing Cell ...... after ADX, chronic treatment with deoxycorticosterone (DOC, a ...

Informations

• Publié par: paul.vallen
• Nombre de lectures: 42
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

Research Summaries Book ENDO 2002 thThe 84 Annual Meeting of The Endocrine Society June 19–22, 2002 Moscone Convention Center, San Francisco, California Press Room: E220 Phone Number: 415-905-1743 Hours: Wednesday-Friday, 7:30am-5:00pm; Saturday, 8:00am-12 noon HOW TO USE THIS BOOK The ENDO 2002 Research Summaries Book has been designed to facilitate media coverage of the th84 Annual Meeting of The Endocrine Society. The highlighted abstracts contained in this book have been identified as those that would be of particular interest to journalists. They were selected from among nearly 2,500 abstracts that will be presented at ENDO 2002. Each abstract in this book is presented in its original scientific form, just as it appears in the Program and Abstracts Book. A news summary of the research, which was prepared in coordination with the research teams, follows each abstract. The summaries include additional background information on the area of research and, in many cases, the source of funding for the research. The original abstracts appear on the left-hand pages and the news summaries on the facing right-hand pages. The abstracts are divided into general topic areas, as denoted in the table of contents. Hot Topics and Clinical Trials Symposia, the first section of this book, features results of up-to-the-minute research and the latest clinical trials. At the end of the book, there are indices of abstracts by abstract number, author, date of presentation, abstract topic area and research funding source. In addition, this book includes a special compilation of abstracts related to the focus of ENDO 2002: “The Impact of the Human Genome on Endocrinology.” These abstracts are marked in the indices with the following symbol: The full ENDO 2002 program is available on The Endocrine Society’s Web site through the On- line Science Planner at www.endo-society.org The Endocrine Society 4350 East West Highway, Suite 500 Bethesda, MD 20814-4426 Phone: [phone]-ENDOCRINE Fax: [phone] www.endo-society.org The Endocrine Society Public Affairs Contacts: Susan Koppi Marisa Lavine Director, Public Affairs Manager, Public Affairs Direct: 301-941-0252 Direct: 301-941-0255 Email: [e-mail] Email: [e-mail] -  Hormone Foundation/Endocrine Society Ad   ENDO 2002 Embargo Policy Unless otherwise noted, all abstracts presented at ENDO 2002 are embargoed until 6:00 a.m. (EST) on Wednesday, June 19, 2002. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to the start of ENDO 2002. For additional information, please contact The Endocrine Society’s Public Affairs department at 301-941-0255 or [e-mail]  Name: _____________________ Organization: _____________ Email: _____________________ Phone: ___________________ 2002 MEDIA SURVEY Please take a few moments to complete the following survey regarding media services at ENDO 2002. We appreciate hearing from you, and we will incorporate your feedback in our future media plans. th1. How did you hear about The Endocrine Society’s 84 Annual Meeting, ENDO 2002? 2. What topics / presentations were of special interest to you at ENDO 2002? 3. Were the printed and on-line meeting materials helpful to you? • Media Advisories / Press Releases: • Science Planner On-Line: • Program and Abstract Book: • Research Summaries Book: • Other: 4. Did you attend any of the press briefings during ENDO 2002? Why or why not? 5. Were you able to arrange interviews with presenters? 6. Was the press room adequately equipped (staff and resources) to facilitate your reporting needs? 7. Are you interested in future Endocrine Society meetings and announcements? 8. How could we serve you better in the future? Comments: Thank you for taking time to fill out this survey. Please leave your completed form with press room staff, or send to: Marisa Lavine, Manager, Public Affairs The Endocrine Society 4350 East West Highway Bethesda, MD 20814 PH: 301-941-0255 FAX: [phone] E-Mail: [e-mail]   TABLE OF CONTENTS 1. Clinical Trials/Hot Topics pp. 1–4 2. Aging pp. 5–22 3. Androgenic Disorders in Women pp. 23–44 4. Bone 45–56 5. Diabetes pp. 57–74 6. Genetics 75–86 7. Glucocorticoids pp. 87–94 8. GnRH pp. 95–100 9. Growth 101–120 10. Hormones and Disease pp. 121–136 11. HPA Axis pp. 137–146 12. Insulin Like Growth Factors pp. 147–154 13. Obesity 155–158 14. Reproduction 159–194 15. Steroid Hormone Action/Biosynthesis pp. 195–204 16. Thyroid pp. 205–220 17. Indices pp. 221–241   CLINICAL TRIALS/HOT TOPICS TAB